When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
TCR2 Therapeutics (TCRR) has priced its public offering of ~4.6M common shares at $30.50/share, for expected gross proceeds of ~$140M.Underwriters' over-allotment is an additional ~688.5K shares. Net proceeds will be used to advance its clinical programs, for R&D activities, working capital and general corporate purposes.Closing date is January 22.Previously (Jan. 19): TCR² Therapeutics to raise $125M capital